Litcius/Paper detail

A Single-Arm Phase 2 Study of Sotorasib Plus Carboplatin and Pemetrexed in Patients With Advanced Nonsquamous NSCLC With KRAS G12C Mutation (WJOG14821L, SCARLET)

Hiroaki Akamatsu, Shinya Sakata, Koichi Azuma, Hiroshige Yoshioka, Takehiro Uemura, Yuko Tsuchiya‐Kawano, Seiya Esumi, Takashi Kurosaki, Yuki Sato, Tomohiro Sakamoto, Kiichiro Ninomiya, Ryo Toyozawa, Yasuto Yoneshima, Takehito Shukuya, Toshiyuki Kozuki, Kana Watanabe, Haruko Daga, Terufumi Kato, Toshiaki Takahashi, Mitsuo Osuga, Yasuhiro Koh, Satoshi Morita, Nobuyuki Yamamoto

2025Journal of Thoracic Oncology14 citationsDOIOpen Access PDF

Topics & Concepts

PemetrexedMedicineCarboplatinKRASLung cancerMutationInternal medicineOncologyCancerCancer researchChemotherapyCisplatinGeneticsColorectal cancerGeneBiologyLung Cancer Treatments and MutationsColorectal Cancer Treatments and StudiesLung Cancer Research Studies
A Single-Arm Phase 2 Study of Sotorasib Plus Carboplatin and Pemetrexed in Patients With Advanced Nonsquamous NSCLC With KRAS G12C Mutation (WJOG14821L, SCARLET) | Litcius